HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Fukuoka Selected Research

Neutropenia

1/2017A randomized, open-label, phase III trial comparing amrubicin versus docetaxel in patients with previously treated non-small-cell lung cancer.
1/2013Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer.
6/2004Combination phase I study of nedaplatin and gemcitabine for advanced non-small-cell lung cancer.
2/2003Randomised phase III trial of irinotecan combined with cisplatin for advanced non-small-cell lung cancer.
8/2001Dose escalation study of irinotecan combined with carboplatin for advanced non-small-cell lung cancer.
7/2000Irinotecan in small-cell lung cancer--Japanese trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Fukuoka Research Topics

Disease

21Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 03/2000
11Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2017 - 05/2000
11Neoplasms (Cancer)
06/2010 - 05/2000
7Lung Neoplasms (Lung Cancer)
07/2010 - 03/2000
6Neutropenia
01/2017 - 07/2000
3Pneumonia (Pneumonitis)
09/2012 - 07/2000
3Thrombocytopenia (Thrombopenia)
06/2004 - 07/2000
3Asthma (Bronchial Asthma)
11/2001 - 01/2001
2Febrile Neutropenia
01/2017 - 01/2013
2Adenocarcinoma
01/2013 - 09/2012
2Breast Neoplasms (Breast Cancer)
10/2002 - 09/2000
2Anemia
12/2001 - 04/2000
2Inflammation (Inflammations)
11/2001 - 06/2001
1Disease Progression
01/2021
1Leukopenia
01/2017
1Interstitial Lung Diseases (Interstitial Lung Disease)
04/2015
1Pancreatic Neoplasms (Pancreatic Cancer)
04/2013
1Proteinuria
01/2013
1Hypertension (High Blood Pressure)
01/2013
1Body Weight (Weight, Body)
01/2013
1Necrosis
05/2007
1Infections
09/2006
1Exanthema (Rash)
09/2006
1Microscopic Polyangiitis
07/2005
1Systemic Vasculitis
07/2005
1Pain (Aches)
08/2002
1Neck Pain (Cervicalgia)
08/2002
1Stomach Neoplasms (Stomach Cancer)
10/2001
1Peripheral Nervous System Diseases (PNS Diseases)
07/2001
1Emphysema
06/2001
1Pulmonary Fibrosis (Fibrosing Alveolitis)
06/2001
1Cytomegalovirus Infections (Inclusion Disease)
04/2001
1Chronic Hepatitis (Chronic Active Hepatitis)
01/2001

Drug/Important Bio-Agent (IBA)

14Irinotecan (Camptosar)FDA LinkGeneric
02/2007 - 03/2000
12Cisplatin (Platino)FDA LinkGeneric
06/2010 - 03/2000
5ErbB Receptors (EGF Receptor)IBA
01/2021 - 06/2003
5Docetaxel (Taxotere)FDA Link
01/2017 - 05/2000
5Gefitinib (Iressa)FDA Link
09/2012 - 06/2003
5Carboplatin (JM8)FDA LinkGeneric
06/2010 - 07/2001
4GemcitabineFDA Link
04/2013 - 05/2000
4Etoposide (VP 16)FDA LinkGeneric
08/2005 - 07/2000
3amrubicinIBA
01/2017 - 05/2000
2Bevacizumab (Avastin)FDA Link
01/2021 - 01/2013
2Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2021 - 04/2015
2PlatinumIBA
01/2013 - 02/2007
2Monoclonal AntibodiesIBA
02/2008 - 05/2000
2Vinorelbine (Navelbine)FDA LinkGeneric
02/2007 - 05/2000
2Topoisomerase I InhibitorsIBA
08/2005 - 07/2001
2Tyrosine Kinase InhibitorsIBA
06/2003 - 05/2000
2Messenger RNA (mRNA)IBA
11/2001 - 06/2000
2Doxorubicin (Adriamycin)FDA LinkGeneric
11/2001 - 09/2000
1Equilibrative Nucleoside Transporter 1IBA
04/2013
1EnzymesIBA
07/2010
1Thymidylate SynthaseIBA
07/2010
1Biological ProductsIBA
07/2010
1ThymidineIBA
07/2010
1sepantroniumIBA
06/2010
1Inhibitor of Apoptosis ProteinsIBA
06/2010
1SurvivinIBA
06/2010
1Platinum Compounds (Compounds, Platinum)IBA
06/2010
1nimotuzumabIBA
02/2008
1soblidotin (TZT 1027)IBA
05/2007
1Alanine Transaminase (SGPT)IBA
09/2006
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
07/2005
1Peroxidase (Myeloperoxidase)IBA
07/2005
1nedaplatinIBA
06/2004
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
02/2003
1bisphenol AIBA
10/2002
1Sulfates (Sulfates, Inorganic)IBA
10/2002
1ErythropoietinFDA Link
12/2001
1Adenosine Triphosphate (ATP)IBA
11/2001
1Theophylline (Theon)FDA LinkGeneric
11/2001
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
11/2001
1Pharmaceutical PreparationsIBA
11/2001
1Cholecalciferol (Vitamin D3)FDA Link
07/2001
1Nerve Growth Factor (NGF)IBA
07/2001
11 alpha,24-dihydroxyvitamin D3 (Tacalcitol)IBA
07/2001
1Anti-Allergic Agents (Antiallergic Agents)IBA
06/2001
1Reactive Oxygen Species (Oxygen Radicals)IBA
06/2001
1suplatast tosilateIBA
06/2001
1Interleukin-8 (Interleukin 8)IBA
06/2001
1DNA (Deoxyribonucleic Acid)IBA
04/2001
1Immunoglobulin M (IgM)IBA
04/2001
1AllergensIBA
01/2001
1Carcinoembryonic AntigenIBA
01/2001
1CamptothecinIBA
01/2001
1OvalbuminIBA
01/2001
1AlkaloidsIBA
01/2001
1quinolineIBA
01/2001
1acarboxyprothrombin (PIVKA)IBA
01/2001
1alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2001
1satraplatin (JM 216)IBA
09/2000
1Antinuclear AntibodiesIBA
08/2000

Therapy/Procedure

8Drug Therapy (Chemotherapy)
01/2021 - 04/2000
5Therapeutics
07/2010 - 07/2001
4Radiotherapy
09/2012 - 04/2000
3Combination Drug Therapy (Combination Chemotherapy)
02/2003 - 07/2001
1Induction Chemotherapy
09/2012
1TP protocol
02/2007
1Wheelchairs (Wheel Chair)
08/2002